These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24911489)

  • 1. Expanding rare disease drug trials based on shared molecular etiology.
    Brooks PJ; Tagle DA; Groft S
    Nat Biotechnol; 2014 Jun; 32(6):515-8. PubMed ID: 24911489
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials of orphan medicines.
    Buckley BM
    Lancet; 2008 Jun; 371(9629):2051-5. PubMed ID: 18555919
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug target gene-based analyses of drug repositionability in rare and intractable diseases.
    Sakate R; Kimura T
    Sci Rep; 2021 Jun; 11(1):12338. PubMed ID: 34117295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new toolkit for conducting clinical trials in rare disorders.
    Abrahamyan L; Diamond IR; Johnson SR; Feldman BM
    J Popul Ther Clin Pharmacol; 2014; 21(1):e66-78. PubMed ID: 24671886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug approvals 2011: focus on companion diagnostics.
    Goozner M
    J Natl Cancer Inst; 2012 Jan; 104(2):84-6. PubMed ID: 22215850
    [No Abstract]   [Full Text] [Related]  

  • 6. Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases.
    Bollyky TJ; Cockburn IM; Berndt E
    Clin Trials; 2010 Dec; 7(6):719-34. PubMed ID: 21109581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A father's fight to help his sons - and fix clinical trials.
    Adam D
    Nature; 2019 Jan; 565(7738):148-151. PubMed ID: 30626961
    [No Abstract]   [Full Text] [Related]  

  • 8. A new toolkit for conducting clinical trials in rare disorders: will this dog hunt?
    Peterson RG; Macleod SM; Klein AV
    J Popul Ther Clin Pharmacol; 2014; 21(1):e79-80. PubMed ID: 24671905
    [No Abstract]   [Full Text] [Related]  

  • 9. Rare Gynecologic Tumors: Coming of Age.
    Gershenson DM; Okamoto A; Ray-Coquard I
    Gynecol Oncol; 2020 Apr; 157(1):1-2. PubMed ID: 32241340
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary Fibrosis Foundation Summit 2015.
    Furlow B
    Lancet Respir Med; 2016 Jan; 4(1):13. PubMed ID: 26673676
    [No Abstract]   [Full Text] [Related]  

  • 11. An analysis of FDA-approved drugs for metabolic diseases.
    Kinch MS; Umlauf S; Plummer M
    Drug Discov Today; 2015 Jun; 20(6):648-51. PubMed ID: 25680688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ethics of non-inferiority trials.
    Menten J; Boelaert M
    Lancet; 2008 Mar; 371(9616):896; author reply 896-7. PubMed ID: 18342679
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients as key partners in rare disease drug development.
    Bronstein MG; Kakkis ED
    Nat Rev Drug Discov; 2016 Nov; 15(11):731-732. PubMed ID: 27444223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The needs of the few.
    Nature; 2010 Jul; 466(7303):160. PubMed ID: 20613796
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel clinical trial designs for targeted therapies
.
    Hsu Schmitz SF
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):695-697. PubMed ID: 28655382
    [No Abstract]   [Full Text] [Related]  

  • 16. More support for clinical trials in children.
    Nature; 2016 Jul; 535(7613):465-6. PubMed ID: 27466087
    [No Abstract]   [Full Text] [Related]  

  • 17. [Benefit assessment in special situations--rare diseases].
    Windeler J; Lange S
    Z Evid Fortbild Qual Gesundhwes; 2008; 102(1):25-30. PubMed ID: 19009938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power of rare diseases: found in translation.
    Fishman MC
    Sci Transl Med; 2013 Sep; 5(201):201ps11. PubMed ID: 24005157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic convergence of rare lymphomas.
    Shingleton JR; Dave SS
    Curr Opin Hematol; 2018 Jul; 25(4):307-314. PubMed ID: 29702524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical considerations for rare diseases drug development.
    Chow SC; Chang YW
    J Biopharm Stat; 2019; 29(5):874-886. PubMed ID: 31454299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.